Baillie Gifford & Co’s Jaguar Health JAGX Stock Holding History

Baillie Gifford & Co’s Portfolio JAGX Stock Details JAGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	–	–	508
2021 Q3	$0	Buy	+1	New	+$12.9M	﹤0.01%	500
2021 Q2	–	Hold	0	–	–	–	477
2021 Q1	–	Hold	0	–	–	–	451

Other funds holding JAGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

OQS

Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co's JAGX Position: Q4 2021 in Review

Baillie Gifford & Co sold out of Jaguar Health (JAGX) in Q4 2021, closing a stake of 1 share.

Baillie Gifford & Co first reported a position in JAGX in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 1 fund tracked by Wall St. Rank holds JAGX as of Q4 2021.

Baillie Gifford & Co reported no remaining Jaguar Health position as of Q4 2021 after selling out during the quarter.
Baillie Gifford & Co sold 1 Jaguar Health share in Q4 2021.
Baillie Gifford & Co first reported a position in Jaguar Health in Q3 2021 and held it in 1 quarter.
Baillie Gifford & Co's Jaguar Health position peaked at $0 in Q3 2021.
1 fund tracked by Wall St. Rank held Jaguar Health as of Q4 2021.

Based on Baillie Gifford & Co's 13F filing for Q4 2021, filed 20 Jan 2022.